SCHEMBL9975871

SCHEMBL9975871

COC(=O)c1sccc1-c1cc[n+](C)cc1C1=CCC(C)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
POLB P06746 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
NPSR1 Q6W5P4 5/20 0.34
MAPT P10636 4/20 0.34
HPGD P15428 2/20 0.34
GAA P10253 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CASP3 P42574 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TSHR P16473 2/20 0.33
PRNP P04156 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9975731 0.80 HPGD (0.42) ALDH1A1SMN1; SMN2POLBKDM4EHTT
SCHEMBL10364876 0.80 KDM4E (0.43) ALDH1A1SMN1; SMN2POLBKDM4EHTT
SCHEMBL10366309 0.78 HPGD (0.42) ALDH1A1SMN1; SMN2POLBKDM4EHTT
SCHEMBL10366653 0.77 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2POLBKDM4EHTT
SCHEMBL16203340 0.77 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2POLBKDM4EHTT
SCHEMBL2107411 0.73 AXL (0.36) ALDH1A1KMT2AMEN1NPSR1HPGD
SCHEMBL9975873 0.73 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2POLBKDM4EHTT
SCHEMBL16866363 0.70 MAPT (0.43) ALDH1A1SMN1; SMN2POLBKDM4EKMT2A
SCHEMBL10366097 0.67 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2POLBKDM4EHTT
SCHEMBL25130595 0.63 ALDH1A1 (0.44) ALDH1A1POLBKDM4EKMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10426762-B2 Inhibitors of hepatitis C virus polymerase COCRYSTAL PHARMA, INC. (US) 2019-10-01 US disclosed
US-9707215-B2 Inhibitors of hepatitis C virus polymerase COCRYSTAL, DISCOVERY, INC. (US) 2017-07-18 US disclosed
US-20150182514-A1 INHIBITORS OF HEPATITIS C VIRUS POLYMERASE COCRYSTAL PHARMA, INC. 2015-07-02 US disclosed
US-20140322165-A1 INHIBITORS OF HEPATITIS C VIRUS POLYMERASE COCRYSTAL DISCOVERY INC (US) 2014-10-30 US disclosed
US-20140322165-A1 INHIBITORS OF HEPATITIS C VIRUS POLYMERASE COCRYSTAL DISCOVERY INC (US) 2014-10-30 US disclosed
US-8771665-B2 Inhibitors of hepatitis C virus polymerase COCRYSTAL DISCOVERY, INC. (US) 2014-07-08 US disclosed
US-20120183496-A1 INHIBITORS OF HEPATITIS C VIRUS POLYMERASE COCRYSTAL DISCOVERY, INC. (US) 2012-07-19 US disclosed
WO-2012083105-A1 INHIBITORS OF HEPATITIS C VIRUS POLYMERASE COCRYSTAL DISCOVERY, INC. (US) 2012-06-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10426762-B2 Inhibitors of hepatitis C virus polymerase POLR2E, POLR2H, GTF3C3 ALDH1A1 743/4885SMN1; SMN2 4863/4885POLB 41/4885
US-20120183496-A1 INHIBITORS OF HEPATITIS C VIRUS POLYMERASE POLR2A, POLR2B, POLR2E ALDH1A1 577/4885SMN1; SMN2 4781/4885POLB 7/4885
US-20150182514-A1 INHIBITORS OF HEPATITIS C VIRUS POLYMERASE POLR2E, POLR2H, GTF3C3 ALDH1A1 743/4885SMN1; SMN2 4863/4885POLB 41/4885
US-20140322165-A1 INHIBITORS OF HEPATITIS C VIRUS POLYMERASE POLR2A, POLR2B, POLR2E ALDH1A1 577/4885SMN1; SMN2 4781/4885POLB 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.